期刊文献+

不同年龄患儿顺式阿曲库铵药代动力学的比较 被引量:1

Pharmacokinetics of cisatracurium in children of different ages
原文传递
导出
摘要 目的比较不同年龄患儿顺式阿曲库铵的药代动力学。方法择期行唇腭裂修复术的患儿24例,ASA分级Ⅰ或Ⅱ级,年龄〈5岁,体重9~26kg。根据年龄将患儿分为2组(n=12),A组:年龄〈2岁;B组:2岁≤年龄〈5岁。麻醉诱导后经10s静脉注射顺式阿曲库铵0.15mg/kg。于顺式阿曲库铵给药后2、4、6、8、10、15、20、30、45、60、90和120min时取桡动脉血样,采用高效液相色谱法检测血浆顺式阿曲库铵浓度,将所得时间.血药浓度数据应用3t07计算机软件处理,得到各项药代动力学参数:消除半衰期、系数常数(A,B)、分布速率常数、消除速率常数、中央分布容积、血浆清除率、表观分布容积、速率常数(K10、K12、K21)。结果顺式阿曲库铵药代动力学过程符合二室模型;与B组比较,A组中央分布容积、表观分布容积和血浆清除率升高(P〈0.05),其余药代动力学参数差异无统计学意义(P〉0.05)。结论患儿顺式阿曲库铵药代动力学过程符合二室模型,2岁以下患儿顺式阿曲库铵中央室分布容积、表观分布容积、血浆清除率明显高于2~5岁患儿。 Objective To study the pharmacokinetics of cisatracurium in children of different ages.Me- thods Twenty-four ASA Ⅰ or Ⅱ children undergoing elective surgery were divided into 2 age groups: group A 〈 2 yr and group B ≥ 2 yr - 〈 5 yr. Arterial blood samples were obtained at 2, 4, 6, 8, 10, 15, 20, 30, 45, 60, 90, 120 min after a bolus dose of cisatracurium (0.15 mg/kg). Plasma concentrations (Cr ) of cisatracurium were measured by high performance liquid chromatography. The data obtained were analyzed by 3P97 pharmacokinetic software. Distribution haft-life( t1/2a ), elimination half life( t1/2a ), A, B, distribution rate constant ( a ), elimina- tion rate constant (fl) , central volume of distribution (Vo), total clearance (CL) and apparent volume of distribution (Vd), Kl0, K12, K21 were recorded. Results The Cp versus time curve for cisatracurium was fitted to a two compartment pharmacokinetic model. There were no significant differences in t1/2a, t1/2β, A, B, a, β,K10, K12, K21 between the 2 groups. Group A had a significantly larger Ve, CL and Vd than group B. Conclusion The Cp versus time curve for cisatracurium is best described by a two-compartment pharmacokinetic model. Vc, CL and Vd are significantly larger in children under the age of 2 than in children between 2 and 5.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2012年第1期51-53,共3页 Chinese Journal of Anesthesiology
关键词 神经肌肉非去极药 儿童 药代动力学 Neuromuscular nondepolarizing agents Child Pharmacokinetics
  • 相关文献

参考文献6

  • 1Boyd AH, Eastwood NB, Parker CJ, et al. Pharmacodynamics of the 1R cis-l' R cis isomer of atracurium (51W89) in health and chronic renal failure. Br J Anaesth, 1995, 74(4) :400-404.
  • 2De Wo~AM, Freeman JA, Scott VL, et al. Pharmacokinetics and pharmacodynamics of cisatracufium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth, 1996, 76 (5):624-628.
  • 3Imbeault K, Withington DE, Varin F. Pharmacokinetics and phar- maeodynamies of a 0.1 mg/kg dose of cisatracurium besylate in chil- dren during N20/O2/propofol anesthesia. Anesth Analg, 2006, 102 (3) :738-743.
  • 4Tran TV, Fiset P, Varin F. Pharmacokinetics and pharmacodynamics of cisatracurium after a short infusion in patients under propofol anes- thesia. Anesth Analg, 1998,87(5) :1158-1163.
  • 5Kisor DF, Schmith VD, Wargin WA, et al. Importance of the or- gan-independent elimination of cisatracurium. Anesth Analg, 1996, 83(5) : 1065-1071.
  • 6郭建荣,卢慧琴,陈小非.顺式阿曲库铵药动学和药效学研究进展[J].中国临床药学杂志,2010,19(3):195-198. 被引量:10

二级参考文献32

  • 1上官王宁,连庆泉,陈小玲,李军,Fang Gao Smith.顺式阿曲库铵对手术患儿的肌松作用[J].中华麻醉学杂志,2005,25(5):395-396. 被引量:18
  • 2上官王宁,连庆泉,李军,陈小玲,FangGao Smith.小儿不同剂量顺式阿曲库铵的肌松作用[J].中华麻醉学杂志,2007,27(1):54-57. 被引量:20
  • 3Adams WA, Mank-Senior J, Jones RS, et al. Cisatracurium in dogs with and without porto-systemic shunts[J]. Vet Anaesth Anal, 2006,33 ( 1 ) : 17.
  • 4Sparr HJ, Beaufout TM, Fuchs-Buder T. Newer neuromuscular blocking agents:how do they compare with established agents.? [J]. Drugs,2001, 61(7):919.
  • 5Dhonneur G, Cerf C,Lagneau F,et al.The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome[J].Anesth Analg,2001,93(2) :400.
  • 6Fodale V, Santamaria LB. Laudanosine, an atracurium and cisatracurium membolite[J], gur J Anaesthesiol, 2002,19(7) :466.
  • 7Schmith VD,Fiedler-Kelly J,Phillips L,et al. Prospective use of population pharmackinetics/pharmacodynamics in the development of cisatracurium[ J]. Phann Res, 1997,14(1 ) :91.
  • 8Sorooshian SS, Stafford MA, Eastwood NB, et al. Pharmacokinetics and plumnacodynamics of cisatracurium in young and elderly adult patients[J].Anesthesiology, 1996,84(5) : 1083.
  • 9Imbeault K, Withington DE, Varin F. Phaxmocokinetics and pharmacodynamics of a 0. 1mg/kg dose of cisatracurium besylate in children during N2O/O2/propofol anesthesia[ J]. Anesth Analg, 2006,102(3) : 738.
  • 10Garg RK. Anesthetic considerations in patients with hepatic failure[J]. hat Anesthesiol Clin,2005,43(3) :45.

共引文献9

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部